Viking Therapeutics, Inc.
Market Cap
$4.11B
P/E Ratio
-11.14
EPS
$-3.19
Dividend Yield
0.00%
52-Week Range
$18.92 — $43.15
Volume
1.51M
Avg Volume
2.98M
Beta
0.79
P/E (TTM)
-11.14
Forward P/E
—
PEG Ratio
0.22
P/S (TTM)
0.00
P/B (TTM)
6.18
P/FCF
-31.40
EV/EBITDA
-28.97x
EV/Sales
—
ROE (TTM)
-0.48%
ROA (TTM)
-0.50%
ROIC
-0.14%
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
0.00%
Debt/Equity
0.00
Current Ratio
9.33
EPS Growth (YoY)
-2.59%
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.77%
EPS Growth (5Y)
-0.59%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-4.22
EPS Est (Next Year)
$-4.57
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$6.19
Price Target Range
Consensus Target: $103.67(191.8% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
115.55M
Float
112.14M
Free Float %
97.05%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2015-04-28
Employees
45
CEO
Brian Lian
Index Membership
—
Website
https://www.vikingtherapeutics.com
Viking Therapeutics, Inc. (VKTX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $4.11B, a P/E ratio of -11.14, VKTX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare VKTX against other stocks using dozens of fundamental and technical filters.
Viking Therapeutics, Inc. (VKTX) has a trailing twelve-month (TTM) P/E ratio of -11.14. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Viking Therapeutics, Inc. (VKTX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Viking Therapeutics, Inc. (VKTX) has a market capitalization of $4.11 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.